FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

40858011000001103: Ibandronic acid 150mg tablets (Crescent Pharma Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Aug 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2374521000001117 Ibandronic acid 150mg tablets (Crescent Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2374541000001110 Ibandronic acid 150mg tablets (Crescent Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ibandronic acid 150mg tablets (Crescent Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Crescent Pharma Ltd) Is a Ibandronic acid 150mg tablets true Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Crescent Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Crescent Pharma Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Crescent Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Crescent Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Crescent Pharma Ltd) Has specific active ingredient Ibandronate sodium monohydrate true Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Crescent Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Crescent Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Crescent Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ibandronic acid true Inferred relationship Existential restriction modifier
Ibandronic acid 150mg tablets (Crescent Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ibandronic acid 150mg tablets (Crescent Pharma Ltd) 1 tablet Has AMP True Ibandronic acid 150mg tablets (Crescent Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start